MedSpeed Collaborates With Sequenom CMM
Published:28-October-2009
By Staff Reporter
To manage and execute its national transportation services
MedSpeed, a provider of integrated transportation services, has partnered with Sequenom Center for Molecular Medicine (Sequenom CMM) to manage and execute its national transportation services.
MedSpeed has strengthened its corporate-based dispatch and analytical capacities and has expanded its operations in order to support Sequenom CMM. Working collaboratively with Sequenom CMM, the company has tailored these and other elements of its service solution to match Sequenom CMM’s current and future needs.
Sequenom CMM is a next-generation CLIA (Clinical Laboratory Improvement Amendments, 1988) molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom, Inc..
MedSpeed provides transportation services exclusively to the healthcare industry. The company designs and executes centralized transportation outsourcing solutions for integrated healthcare delivery networks, independent clinical laboratories, blood banks, and institutional pharmacies.
